MarketCap
Facebook
X
TelegramKindred Biosciences, Inc. P/B Ratio 2011-2026 | KIN
Annual P/B Ratio Kindred Biosciences, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 2.91 | 4.29 | 3.35 | 2.62 | 2.22 | 0.854 | 1.2 | 0.973 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.29 | 0.854 | 2.3 |
P/B Ratio of other stocks in the Biotechnology industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M |  Germany |
 |
Amphastar Pharmaceuticals
AMPH
|
1.58 | $ 21.77 | 1.68 % | $ 1.02 B |  USA |
 |
I-Mab
IMAB
|
1.12 | - | - | $ 866 M |  China |
 |
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | USA |
 |
Midatech Pharma plc
MTP
|
7.56 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | USA |
 |
Aptorum Group Limited
APM
|
0.485 | $ 0.92 | 3.05 % | $ 6.76 M | China |
 |
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M |  France |
 |
Genfit SA
GNFT
|
596 | - | 2.54 % | $ 160 B | France |
 |
ACADIA Pharmaceuticals
ACAD
|
4.36 | $ 22.44 | 2.16 % | $ 3.72 B | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | USA |
 |
Esperion Therapeutics
ESPR
|
-1.86 | $ 2.02 | 5.76 % | $ 420 M | USA |
 |
Advaxis
ADXS
|
0.113 | - | -9.65 % | $ 45.9 M | USA |
 |
AIkido Pharma
AIKI
|
0.492 | - | 1.93 % | $ 17.4 M | USA |
 |
Galectin Therapeutics
GALT
|
-1.41 | $ 2.42 | 3.65 % | $ 155 M | USA |
 |
Akouos
AKUS
|
0.736 | - | 0.23 % | $ 488 M | USA |
 |
Allakos
ALLK
|
0.674 | - | - | $ 28.6 M | USA |
 |
AlloVir
ALVR
|
-0.258 | - | 4.14 % | $ 49.1 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
0.198 | - | -11.43 % | $ 502 K | USA |
 |
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - |  Russia |
 |
Heron Therapeutics
HRTX
|
13.8 | $ 1.26 | 6.3 % | $ 210 M | USA |
 |
Applied Molecular Transport
AMTI
|
0.364 | - | - | $ 10.1 M | USA |
 |
ImmuCell Corporation
ICCC
|
2.15 | $ 8.28 | -0.84 % | $ 74.7 M | USA |
 |
Aeterna Zentaris
AEZS
|
0.781 | - | 5.93 % | $ 314 M |  Canada |
 |
Brainstorm Cell Therapeutics
BCLI
|
-0.815 | - | -2.5 % | $ 5.88 M | USA |
 |
Applied Therapeutics
APLT
|
-31.5 | - | - | $ 8.42 M | USA |
 |
Aptinyx
APTX
|
0.248 | - | -39.0 % | $ 4.57 M | USA |
 |
AgeX Therapeutics
AGE
|
0.00262 | - | -10.17 % | $ 12.2 K | USA |
 |
Aravive
ARAV
|
5.67 | - | -13.39 % | $ 1.45 M | USA |
 |
InflaRx N.V.
IFRX
|
1.41 | $ 1.53 | 3.38 % | $ 152 M | Germany |
 |
Aridis Pharmaceuticals
ARDS
|
-0.17 | - | 17.91 % | $ 11.1 M | USA |
 |
BioNTech SE
BNTX
|
5.29 | $ 103.31 | -2.04 % | $ 27.2 B | Germany |
 |
Avenue Therapeutics
ATXI
|
0.293 | - | -52.27 % | $ 4.45 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.382 | - | - | $ 26.5 M | USA |
 |
Aquestive Therapeutics
AQST
|
-13.9 | $ 4.14 | 1.47 % | $ 443 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
18.2 | $ 23.57 | 1.33 % | $ 3 B | USA |
 |
Innate Pharma S.A.
IPHA
|
1.36 | $ 1.39 | 0.72 % | $ 235 M | France |
 |
Inventiva S.A.
IVA
|
6.02 | $ 5.18 | 0.49 % | $ 138 M | France |
 |
Jaguar Health
JAGX
|
-0.0512 | $ 0.36 | -8.39 % | $ 840 K | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.994 | - | - | $ 7.46 M |  Israel |
 |
Autolus Therapeutics plc
AUTL
|
1.81 | $ 1.46 | 1.04 % | $ 389 M | Britain |
 |
Aptose Biosciences
APTO
|
-0.511 | - | -45.71 % | $ 1.2 M | Canada |
 |
AstraZeneca PLC
AZN
|
2.07 | - | - | $ 96.9 B | Britain |
 |
KalVista Pharmaceuticals
KALV
|
-308 | $ 20.08 | 2.29 % | $ 1.08 B | Britain |
 |
AVROBIO
AVRO
|
0.594 | - | 1083.1 % | $ 745 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
32 | $ 2.99 | 2.05 % | $ 4.92 M | Israel |
 |
BioDelivery Sciences International
BDSI
|
1.64 | - | -4.8 % | $ 255 M | USA |
 |
Kazia Therapeutics Limited
KZIA
|
7.11 | $ 12.42 | 1.26 % | $ 1.65 B |  Australia |
 |
BeiGene, Ltd.
BGNE
|
75.9 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Akero Therapeutics
AKRO
|
4.34 | - | - | $ 3.67 B | USA |